Tumor Mutational Burden and COVID-19: A Pathologist’s Perspective

Episode
40
Soundcloud
Share

The latest episode of Lung Cancer Considered focuses on a recent publication in IASLC's Journal of Thoracic Oncology that features new guidelines on Tumor Mutational Burden as well as the effects of COVID-19. This episode features a conversation between host Dr. Marty Edelman; Dr. Lynette Scholl an associate professor of Pathology at Harvard Medical School and an associate pathologist, Pathology at Brigham And Women's Hospital; and Dr. John Longshore director of Molecular Pathology at Carolinas Pathology Group, Atrium Health, Carolinas HealthCare System.

Guest
Lynette Sholl
Dr. Lynette Sholl

MD

Associate Professor of Pathology and Associate Pathologist
Brigham and Women's Hospital, Harvard Medical School

Other Podcast

New Drug Approval - Release (TDXd)
Episode
118
WCLC 2022 Wrap Up
Episode
117
WCLC 2022 Daily Highlights - August 9
Episode
116